Arthur, C K <br/><br/>
Combined interferon alfa-2a and cytosine arabinoside as first-line treatment for chronic myeloid leukemia.  [electronic resource] 

 -  Acta haematologica  1993 
 - 15-21 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0001-5792 
<br/><br/><label>Standard No.: </label>10.1159/000204580  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Child<br/>Cytarabine--administration & dosage<br/>Female<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Male<br/>Metaphase<br/>Middle Aged<br/>Polymerase Chain Reaction<br/>Recombinant Proteins